NEW YORK, Feb. 11, 2020 /PRNewswire/ --
US Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review
Read the full report: https://www.reportlinker.com/p05825743/?utm_source=PRN
This new report contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital cancer diagnostics market, including: -Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next 5 years. -Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. -Test volume and sales forecasts for 40 cancer diagnostic procedures performed in US hospitals. -Current instrumentation technologies and feature comparison of leading analyzers. -Sales and market shares of leading suppliers. -Emerging diagnostic technologies and their potential market applications. -Product development opportunities. -Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in RandD, collaborative arrangements and business strategies. -Business opportunities and strategic recommendations for suppliers.Contains 567 pages and 50 tables Companies Profiled Competitive Assessments - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Elitech Group - Enzo Biochem - Fujirebio - Grifols - GSK Biologicals - Hologic - Leica Biosystems - Lonza - Ortho-Clinical Diagnostics - PerkinElmer - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens Healthineers - Takara Bio - Thermo Fisher - WakoRead the full report: https://www.reportlinker.com/p05825743/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
Advertisement
US Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review
Advertisement
Read the full report: https://www.reportlinker.com/p05825743/?utm_source=PRN
This new report contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital cancer diagnostics market, including: -Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next 5 years. -Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. -Test volume and sales forecasts for 40 cancer diagnostic procedures performed in US hospitals. -Current instrumentation technologies and feature comparison of leading analyzers. -Sales and market shares of leading suppliers. -Emerging diagnostic technologies and their potential market applications. -Product development opportunities. -Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in RandD, collaborative arrangements and business strategies. -Business opportunities and strategic recommendations for suppliers.Contains 567 pages and 50 tables Companies Profiled Competitive Assessments - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Elitech Group - Enzo Biochem - Fujirebio - Grifols - GSK Biologicals - Hologic - Leica Biosystems - Lonza - Ortho-Clinical Diagnostics - PerkinElmer - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens Healthineers - Takara Bio - Thermo Fisher - WakoRead the full report: https://www.reportlinker.com/p05825743/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
View original content:http://www.prnewswire.com/news-releases/us-hospital-cancer-diagnostics-market-forecasts-for-major-tumor-markers-supplier-shares-by-test-competitive-landscape-innovative-technologies-instrumentation-review-301002699.html
SOURCE Reportlinker
